
Livixiga 10mg Tablet
Marketer
Lividus Pharmaceuticals Pvt Ltd
Salt Composition
Dapagliflozin (10mg)
Overview Livixiga 10mg Tablet
Dapagliflozin 10mg tablets are prescribed, either independently or alongside other medications, for managing type 2 diabetes. The tablets regulate elevated blood glucose, thereby minimizing the risk of severe diabetic complications and contributing to heart disease prevention. Dapagliflozin 10mg may be ingested with or without food, consistently at the same time daily, as determined by your physician. Discontinuation requires medical consultation, as abrupt cessation can elevate blood sugar, potentially resulting in severe complications such as renal impairment and vision loss. This medication complements a comprehensive treatment plan encompassing a balanced diet, regular physical activity, and weight management, as recommended by your doctor. Commonly reported side effects include vaginal yeast infections, upper respiratory tract inflammation (nasopharyngitis), and urinary tract infections. Dehydration is a possibility; increased fluid intake is advised. Practicing good hygiene can reduce the incidence of genital fungal infections. Prior to commencement, disclose any kidney or liver conditions, urinary tract infections, or diuretic use to your doctor. Pregnant or lactating individuals should seek medical advice before use. Limit alcohol consumption, as it may heighten the risk of certain adverse effects. Regular blood glucose monitoring is crucial while using this medication.
Uses of Livixiga 10mg Tablet
Managing type 2 diabetes
Major Benefits of Livixiga 10mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 10mg Livixiga tablet whole; avoid crushing, chewing, or breaking it. While Livixiga can be taken with or without food, consistency in timing is recommended.
Common Side effects of Livixiga 10mg Tablet:
- Polyuria
- Nausea
- Vomiting
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
How to use Livixiga 10mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Livixiga 10mg Tablet whole; do not crush, chew, or break it. This medication can be administered with or without food, however, consistent timing is recommended.
How Livixiga 10mg Tablet works:
Dapagliflozin 10mg tablets are used to manage type 2 diabetes. Their mechanism of action involves the excretion of surplus glucose via the kidneys.
SAFETY ADVICE
AlcoholUNSAFE
Combining Livixiga 10mg tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Dapagliflozin 10mg tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Livixiga 10mg tablets while breastfeeding is likely inadvisable. Available data from human studies indicate a potential for the medication to transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Livixiga 10mg tablets is likely inadvisable for individuals with impaired kidney function and should be avoided. Medical advice is recommended.
LiverSAFE IF PRESCRIBED
For patients with liver conditions, Livixiga 10mg tablets are considered safe. No alteration of the Livixiga 10mg tablet dosage is advised.
What if you forget to take Livixiga 10mg Tablet :
Should you forget a Livixiga 10mg Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Livixiga 10mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Phenolic Glycoside Derivative |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Behavioral Class | Sodium-glucose cotransporter 2 (SGLT2) inhibitors |
